Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Stacey Burns

Anesthesiology Boston, MA Medical Doctor

NPI 1114458411 CMS profile 9011296

75 Francis St, Boston, MA 02115

Open in the dashboard

General payments

$7,239

119 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stacey Burns of Boston, MA is reported in the CMS Open Payments database as having received $7,239 across 119 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $79 6
2024 General $982 21
2023 General $1,651 33
2022 General $2,522 26
2021 General $2,005 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stacey Burns
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Stacey Burns were reported at $79. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Stacey Burns Anesthesiology median Middle half National median
2019 $0 $72 $23–$151 $163
2020 $0 $36 $17–$120 $114
2021 $2,005 $49 $21–$135 $132
2022 $2,522 $52 $22–$144 $149
2023 $1,651 $53 $23–$143 $160
2024 $982 $55 $25–$150 $164
2025 $79 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $3,081 33 payments
  2. Medtronic, Inc. $1,839 31 payments
  3. Abbott Laboratories $930 12 payments
  4. MML US, Inc. $733 37 payments
  5. Vertos Medical, Inc. $327 3 payments
  6. Saluda Medical Americas, Inc. $151 1 payment
  7. Nevro Corp. $127 1 payment
  8. SI-BONE, Inc. $52 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,643 107 payments
  2. Travel and Lodging $1,597 12 payments
Products named General payments · program years 2021–2025
  1. Superion Indirect Decompression System $1,151 8 payments
  2. WaveWriter Alpha Prime 16 $1,127 14 payments
  3. INTELLIS ADAPTIVESTIM $1,096 15 payments
  4. Proclaim IPG $833 10 payments
  5. ReActiv8 $733 37 payments
  6. WAVEWRITER ALPHA $649 7 payments
  7. mild Device Kit $327 3 payments
  8. SYNCHROMEDII $237 2 payments
  9. INTELLIS $234 7 payments
  10. Evoke SCS $151 1 payment
  11. Other $650 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

82

Median for Anesthesiology: 322

Drug cost

$4,340

Median for Anesthesiology: $8,738

Branded share of claims

0%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lidocaine Generic 14 $2,698
Pregabalin Generic 20 $1,043
Tizanidine Hcl Generic 29 $339
Gabapentin Generic 19 $260

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$61,197

Of which drugs: $1,534

Medicare patients

174

Average age 72

Services billed

4,558

121 women, 53 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Depression 34%
Chronic kidney disease 29%
Diabetes 27%
Ischemic heart disease 24%
Cancer 24%
Osteoporosis 23%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 40 mg J1030 Office 40 77 $377
Injection, methylprednisolone acetate, 1 mg J1010 Office 51 3,380 $357
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 13 145 $11

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record